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Sir
In the January 1999 issue of the Journal, Lipworth et al (1999)
reported that during the second and third trimester of pregnancy,
Chinese women in Shanghai, China had significantly higher levels
of several gestational hormones (oestrogens, prolactin, growth
hormone) than Caucasian women in Boston, USA (Lipworth et al,
1999). The study indicates that women living in low-risk areas for
breast cancer may have hormonal profiles during pregnancy that
would stimulate the maturation of mammary cells to a fuller
extent, as compared to women in high-risk areas.
A few aspects of the study make difficult its interpretation.
Chinese women in the study were on average 6 years younger than
American women (mean 25.1 vs 31.0 respectively). Although the
literature on the relationships between maternal age, parity and
pregnancy hormones is limited, existing evidence suggests that
maternal age is an important predictor of pregnancy oestrogen
levels. It has been shown that during the third trimester of preg-
nancy, total oestrogen and oestradiol levels are highest among
women aged 20–24, intermediate among women older than 25,
and lowest among women below age 20 (Panagiotopoulou et al,
1990). Lipworth et al stated that their results remained essentially
unchanged after controlling for maternal age but these data were
not reported. It would have been more informative if the results
had been presented stratified by age.
Parity is another factor that could affect hormone levels during
pregnancy. There is evidence that maternal levels of free oestradiol
are higher in the first, as compared to the second, pregnancy
(Bernstein et al, 1986). Therefore, reporting the results stratified
by parity would have been more helpful, especially considering
that 36.8% of American women in the study had a previous full-
term pregnancy, as compared to only 3% of Chinese women.
If the authors could provide convincing evidence that the ample
differences in maternal age and parity between the two popula-
tions have been taken into account appropriately, the study by
Lipworth et al raise the interesting possibility that women in an
area with a low incidence of breast cancer have a distinct preg-
nancy hormone profile characterized by higher levels of oestro-
gens and other mammotrophic hormones. Such hormone profile
could advance the development and full maturation of breast cells
making them less susceptible to carcinogenesis, as postulated by
Russo et al (1982; 1994). In this connection, it would have been
of particular interest to have measured pregnancy hormones
promoting breast differentiation, such as human chorionic
gonadotropin (Russo et al, 1990) and relaxin (Bani et al, 1986).
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Sir
We thank Dr Akhmedkhanov and colleagues for their useful ideas
about human chorionic gonodotropin and relaxin and their
thoughtful and sensible biologic considerations. In particular, the
idea that high levels of hormones during pregnancy might stimu-
late early breast cell maturation is one of the explanations we are
considering for the intrauterine effects on cancer occurrence in the
offspring. With respect to the issue of confounding by maternal
age and parity, because the findings of higher hormone levels
among Chinese women compared with Caucasian women were
unexpected for us, we evaluated in detail every possible
confounder, including maternal age and parity. When the data
were stratified by maternal age (Table 1) or parity (Table 2),
Chinese women consistently displayed higher mean levels of the
measured hormones at both visits, with the possible exception of
progesterone during the second visit, as indicated in our earlier
report. (Since confounding does not depend on statistical signifi-
cance, and in the interest of saving space, we have not presented
the confidence interval around the mean.) Thus, we can assure Dr
Akhmedkhanov and colleagues, and Journal readers, that there
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was no effect when our results were adjusted for maternal age and
parity.
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Table 1 Serum levels of studied hormones at 16 and 27 completed weeks of gestation among pregnant women in Boston, USA (n = 304) and in Shanghai,
China (n = 334), stratified by maternal age
Age ≤ 20 Age 20–24 Age 25–29 Age 30+
Sample 1 Sample 2 Sample 1 Sample 2 Sample 1 Sample 2 Sample 1 Sample 2
Hormone Mean Mean Mean Mean Mean Mean Mean Mean
Estradiol (E2) Boston 16.7 47.7 14.7 38.1 15.8 39.9 13.4 38.8
nmol l–1 Shanghai 17.0 – 20.7 49.5 20.3 46.9 21.9 44.8
Estriol (E3) Boston 3.01 14.3 3.7 14.6 4.1 13.5 3.7 14.1
nmol l–1 Shanghai 5.0 – 6.1 22.6 6.4 20.8 6.7 21.2
Prolactin Boston 25.9 80.1 39.2 65.2 47.2 89.6 44.0 92.4
µ g l–1 Shanghai 30.0 – 58.5 111.5 67.0 123.5 71.7 119.7
Progesterone Boston 88.6 167.0 104.9 248.3 136.3 263.5 132.6 263.9
nmol l–1 Shanghai 129.0 – 143.1 249.5 141.5 237.2 148.4 262.5
Growth hormone Boston 13.7 1.3 1.4 0.6 3.3 0.9 2.9 0.9
mU l–1 Shanghai 5.9 – 4.2 1.9 3.3 1.5 2.8 1.7
Albumin Boston 37.4 32.5 41.6 37.4 40.5 37.0 40.1 36.3
g l–1 Shanghai 44.7 – 43.6 40.0 42.8 39.1 42.3 38.9
SHBGa Boston 417.3 344.2 312.6 417.1 381.1 431.8 356.1 423.7
nmol l–1 Shanghai 447.1 – 437.7 496.4 416.0 446.9 428.4 475.0
aSex hormone-binding globulin.
Table 2 Serum levels of studied hormones at 16 and 27 completed weeks of gestation among pregnant women in Boston, USA (n = 304) and in Shanghai,
China (n = 334), stratified by maternal parity
No previous livebirths One previous livebirth
Sample 1 Sample 2 Sample 1 Sample 2
Hormone Mean Mean Mean Mean
Estradiol (E2) Boston 15.4 42.2 11.8 33.9
nmol l–1 Shanghai 20.8 48.4 17.6 39.7
Estriol (E3) Boston 3.9 14.2 3.8 13.7
nmol l–1 Shanghai 6.3 22.0 4.8 19.3
Prolactin Boston 50.4 95.9 35.0 83.5
µ g l–1 Shanghai 63.3 116.4 50.6 103.4
Progesterone Boston 135.3 269.2 129.2 253.4
nmol l–1 Shanghai 143.4 248.3 138.2 231.6
Growth hormone Boston 3.1 1.0 2.8 0.8
mU l–1 Shanghai 3.7 1.8 1.5 1.2
Albumin Boston 40.5 36.7 39.7 36.1
g l–1 Shanghai 43.1 39.6 43.2 38.8
SHBGa Boston 372.1 436.1 345.9 408.1
nmol l–1 Shanghai 429.7 478.2 414.6 518.6
aSex hormone-binding globulin.
Serum lactate dehydrogenase isoenzyme 1 as a
prognostic predictor for metastatic testicular
germ cell tumours
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Sir
In a recent letter to the editor, Shamash et al (2000) argued that a
raised serum lactate dehydrogenase catalytic concentration (S-LD)
prior to induction chemotherapy for patients with germ cell tumours
predicted a poor outcome. They referred to increasing evidence for a
raised S-LD before first-line chemotherapy being as good if not
better than serum human chorionic gonadotropin concentration (S-
hCG), as found in, e.g., International Germ Cell Cancer
Collaboratory Group (IGCCCG) (von Eyben et al, 1983; Mead and
Stenning, 1997). Correspondingly, the fifth edition of the TNM (T =